Dr. Xinxin Ding named 2023 ASPET Fellow

Xinxin Ding, PhD, a professor and head of the Department of Pharmacology and Toxicology at the University of Arizona R. Ken Coit College of Pharmacy, was named a 2023 American Society for Pharmacology and Experimental Therapeutics (ASPET) Fellow. 

"I am humbled," said Dr. Ding, who is a member of the BIO5 Institute. "It's a great honor and I will take it as a reminder to work harder for my fellow pharmacologists." 

ASPET Fellows have dedicated their careers to the field of pharmacology and have made exceptional contributions to its advancement. To be recognized is a prestigious honor bestowed on the Society's most distinguished members. 

Dr. Ding has contributed to ASPET in several ways, by serving as Editor-in-Chief for ASPET's journal Drug Metabolism and Disposition, ASPET Council as secretary/treasurer, and on several of its committees, including the publications committee and the journals taskforce. Dr. Ding has served as pharmacology and toxicology department head for five years. 

"Our college is playing important roles in advancing the field of pharmacology," he said. "Our faculty conducts cutting edge pharmacology research. They regularly publish their research findings in ASPET journals and they serve ASPET and pharmacology in various professional capacities, such as editors or editorial board members and division leaders. We also train the next generation of pharmacologists through our PhD program in Pharmacology and Toxicology." 

ASPET’s mission is to be a “professional home for educators, students, researchers, health care practitioners and other professionals working to advance pharmacology research, exchange knowledge and increase the impact and influence of this scientific discipline.” The society’s 4,000 members conduct basic and clinical pharmacological research and work for universities, government, large pharmaceutical companies, small biotech companies and nonprofit organizations.